Skip to main content
OpenTrials

Clinical trial condition

Bronchiolitis Obliterans

Explore clinical trials studying Bronchiolitis Obliterans. Study availability and eligibility vary by location and protocol.

516 public trials 84 recruiting studies
Refine in advanced search Browse all conditions

Bronchiolitis Obliterans trial results

Completed

A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)

NCT03112603

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Incyte Investigative Site Tucson, Arizona, United States
  • Incyte Investigative Site Duarte, California, United States
  • Incyte Investigative Site La Jolla, California, United States
  • Incyte Investigative Site Los Angeles, California, United States
View all 191 locations
View Trial Details
Completed

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

NCT02036970

Conditions
Acute Interstitial Pneumonitis, Bronchial Diseases, Bronchiolitis, +32 more
Locations
  • Banner University Medical Center, Phoenix Advanced Lung Disease Institute Phoenix, Arizona, United States
  • Arizona Pulmonary Specialists Phoenix, Arizona, United States
  • Cedars Sinai Medical Center Beverly Hills, California, United States
  • VA Healthcare System of Greater Los Angeles Los Angeles, California, United States
View all 32 locations
View Trial Details
Completed

Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213

NCT05305989

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • City of Hope Site Number : 050 Duarte, California, United States
  • Stanford Cancer Center Site Number : 108 Stanford, California, United States
  • Washington University School of Medicine Site Number : 125 St Louis, Missouri, United States
  • University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center Site Number : 132 Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Study of Efficacy and Safety of CML-CP Patients Treated With Asciminib Versus Best Available Therapy, Previously Treated With 2 or More Tyrosine Kinase Inhibitors

NCT04795427

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +22 more
Locations
  • Novartis Investigative Site Chongqing, Chongqing Municipality, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shenzhen, Guangdong, China
  • Novartis Investigative Site Zhengzhou, Henan, China
View all 20 locations
View Trial Details

Related conditions